The global biologics market is projected to reach USD 567.96 Billion in 2028 at a steady revenue CAGR of 8.4% over the forecast period, according to latest analysis by Emergen Research. Some key factors attributed to steady market revenue growth include rising demand for monoclonal antibodies, recombinant hormones/proteins, gene-based cellular-based biologics, vaccines, and molecular therapy, etc. in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others. Also, rising use of biologics for the treatment of autoimmune diseases, comprising various arthritis types, including ankylosing spondylitis, rheumatoid arthritis, and psoriatic arthritis, is playing a crucial role in driving revenue growth of the global biologics market. Biologics function by creating an inflammation disruption, thereby resulting in a reduction in joint pain.
Emergen Research's latest market research report, titled Global Biologics Market, provides estimated market size and shares, latest industry trends, global market growth rates, key drivers and opportunities, constraints, product segmentation, and major market players. Cost structure, market size, competitive landscape, product portfolio and specifications, and company profiles.
Get more information on market share in different regions by downloading the sample PDF report at MINUTES @ https://www.emergenresearch.com/request-sample/61
The Global Biologics Market report assesses the historical and current data along with a thorough analysis of the market dynamics. The report also sheds light on the significant market growth driving and restraining factors that are anticipated to influence the market growth through the forecast period. The report explores the effects of the pandemic on the market and its key segments and regions. It also offers a forecast estimation of the market growth in a post-COVID-19 scenario.
Our Free Sample Reports Includes :
In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, Share, Includes Updated List of figures and tables.
Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Emergen Research methodology.
Competitive Terrain:
The global Biologics industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
Key Players Operating in the Global Biologics Market are:
Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung BioLogics, Merck Co. Inc., Celltrion, AbbVie Inc., Johnson Johnson Services Inc., Eli Lilly Company, F Hoffman La Roche, Addgene, Novartis AG, and GlaxoSmithKline
The Research covers the following objectives:
To study and analyze the Global Biologics Market by key regions/countries, product type and application, history data from forecast to 2030.
To understand the structure of Biologics Market by identifying its various sub-segments.
Focuses on the key global Biologics Market manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter’s five forces analysis, SWOT analysis and development plans in the next few years.
To analyze the Biologics Market with respect to individual growth trends, future prospects, and their contribution to the total market.
Browse Detailed Biologics Market Research Analysis report @ https://www.emergenresearch.com/industry-report/biologics-market
Segments Covered in this report are:
Source Outlook (Revenue, USD Billion; 2018-2028)
- Microbial
- Mammalian
- Others
Product Type Outlook (Revenue, USD Billion; 2018-2028)
- Monoclonal Antibodies
- Vaccines
- Recombinant Hormones/Proteins
- Cellular-Based Biologics
- Gene-Based Biologics
- Others
Application Outlook (Revenue, USD Billion; 2018-2028)
- Cancer
- Infectious Diseases
- Immunological Diseases
- Cardiovascular Diseases
- Hematological Disorders
- Others
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/61
Regional Outlook:
- North America (the U.S., Canada, Mexico)
- Europe (the U.K., Germany, France, Italy)
- Asia Pacific (India, China, Japan, Korea)
- Latin America (Brazil, Argentina, Ecuador, Chile)
- Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran)
Latest Published Reports by Emergen Research:
Cell-Free DNA (cfDNA) Testing Market
Assisted Reproductive Technology (ART) Market
Synthetic Blood Substitutes Market
Synthetic Blood Substitutes Market
About us :
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Thank you for reading our report. To find more details on the report or to inquire about its customization, please let us know, and we will offer you the report as per your needs.
